PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

PharmaShots Interview: In Conversation with Portage’s CEO and Director, Dr. Ian Walters, Where he Shares Insights on Ongoing Clinical-Stage and Development Programs

PharmaShots Interview: In Conversation with Portage’s CEO and Director, Dr. Ian Walters, Where he Shares Insights on Ongoing Clini...

June 8, 2022

A ray of hope? Cancer Disappeared Unanticipatedly in Every Patients

A ray of hope? Cancer Disappeared Unanticipatedly in Every Patients

June 8, 2022

Moderna Reports Results of Bivalent Booster mRNA -1273.214 in P-II/III Trial Demonstrated Superior Antibody Response Against Omicron

Moderna Reports Results of Bivalent Booster mRNA -1273.214 in P-II/III Trial Demonstrated Superior Antibody Response Against Omicr...

June 8, 2022

$Roche’s Lunsumio (mosunetuzumab) Receives EC’s Approval for the Treatment of Relapsed or Refractory Follicular Lymphoma$

Roche’s Lunsumio (mosunetuzumab) Receives EC’s Approval for the Treatment of Relapsed or Refractory Follicular Lymphoma

June 8, 2022

SeaStar Medical and LMF Published Results of Selective Cytopheretic Device in (Pilot SCD 005) Study for COVID-19 in SCCM 2022, Critical Care Explorations

SeaStar Medical and LMF Published Results of Selective Cytopheretic Device in (Pilot SCD 005) Study for COVID-19 in SCCM 2022, Cri...

June 8, 2022

Sanofi’s Dupixent (dupilumab) Receives the US FDA’s Approval for the Treatment of Atopic Dermatitis in Children Aged 6 months to 5 years

Sanofi’s Dupixent (dupilumab) Receives the US FDA’s Approval for the Treatment of Atopic Dermatitis in Children Aged 6 months to 5...

June 8, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us